Hannah Rashdan
YOU?
Author Swipe
View article: Machine learning prediction for early-stage melanoma outcomes: recurrence-free survival, disease-specific survival, and overall survival
Machine learning prediction for early-stage melanoma outcomes: recurrence-free survival, disease-specific survival, and overall survival Open
This study compared machine-learning models for predicting recurrence-free survival (RFS), disease-specific survival (DSS), and overall survival (OS) using clinicopathologic data from 1,621 stage I/II primary cutaneous melanoma patients. O…
View article: Individualized melanoma risk prediction using machine learning with electronic health records
Individualized melanoma risk prediction using machine learning with electronic health records Open
Background Melanoma is a lethal form of skin cancer with a high propensity for metastasizing, making early detection crucial. This study aims to develop a machine learning model using electronic health record data to identify patients at h…
View article: Surgical margin reduction in excision of cutaneous melanoma: A retrospective analysis
Surgical margin reduction in excision of cutaneous melanoma: A retrospective analysis Open
View article: Timing of cutaneous immune-related adverse events impacts survival in patients with cancer treated with immune-checkpoint inhibitors: A multi-institutional cohort study
Timing of cutaneous immune-related adverse events impacts survival in patients with cancer treated with immune-checkpoint inhibitors: A multi-institutional cohort study Open
View article: 1241 Clusters of multi-organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients: a population-level study
1241 Clusters of multi-organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients: a population-level study Open
Background Immune-related adverse events (irAEs) induced by immune checkpoint inhibitor (ICI) therapy can involve multiple organ systems, of which cutaneous irAEs (c-irAEs) are the most common.1–5 Understanding co-occurrence pat…
View article: 554 Clinical outcomes of patients treated with immune checkpoint inhibitor therapy for early-stage melanoma recurrence: a retrospective cohort study
554 Clinical outcomes of patients treated with immune checkpoint inhibitor therapy for early-stage melanoma recurrence: a retrospective cohort study Open
Background Melanoma mortality has steadily decreased since the introduction of immune checkpoint inhibitors (ICIs) to manage advanced-stage disease (stage III/IV).1 Although ICIs have prolonged survival, this therapeutic class i…
View article: Pre-existing inflammatory disease predicts cutaneous immunotherapy toxicity development: A multi-institutional cohort study
Pre-existing inflammatory disease predicts cutaneous immunotherapy toxicity development: A multi-institutional cohort study Open
View article: Development and validation of time-to-event models to predict metastatic recurrence of localized cutaneous melanoma
Development and validation of time-to-event models to predict metastatic recurrence of localized cutaneous melanoma Open
View article: Checkpoint inhibitor antibody type influences the development of cutaneous immune-related adverse events: A multi-institutional study
Checkpoint inhibitor antibody type influences the development of cutaneous immune-related adverse events: A multi-institutional study Open
View article: Pre-Existing Inflammatory Disease Predicts Cutaneous Immunotherapy Toxicity Development: A Multi-Institutional Cohort Study
Pre-Existing Inflammatory Disease Predicts Cutaneous Immunotherapy Toxicity Development: A Multi-Institutional Cohort Study Open
Background Relationships between pre-existing inflammatory diseases (pIDs) and cutaneous immune-related adverse events (cirAEs) have not been well-studied. This study is to investigate associations between pIDs and cirAEs among immune-chec…
View article: Transient Erythema Elevatum Diutinum Associated With HIV Viremia
Transient Erythema Elevatum Diutinum Associated With HIV Viremia Open
View article: Underuse of sentinel lymph node biopsy for early-stage melanoma
Underuse of sentinel lymph node biopsy for early-stage melanoma Open
View article: Increased risk of cutaneous immune-related adverse events in patients treated with talimogene laherparepvec and immune checkpoint inhibitors: A multi-hospital cohort study
Increased risk of cutaneous immune-related adverse events in patients treated with talimogene laherparepvec and immune checkpoint inhibitors: A multi-hospital cohort study Open